SAB Biotherapeutics (SABS) Income towards Parent Company (2020 - 2026)
SAB Biotherapeutics (SABS) posted Income towards Parent Company of -$22.49 million for Q2 2026, compared with -$10.11 million a year earlier.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Income towards Parent Company (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income towards Parent Company at SAB Biotherapeutics was -$12.78 million; for FY2025, it was $13.27 million.
- Annual Income towards Parent Company shows a five-year compound annual growth rate of -8.0% (FY2020 to FY2025).
- In prior years, SAB Biotherapeutics' Income towards Parent Company was -$34.11 million in FY2024, -$42.19 million in FY2023, -$18.74 million in FY2022 and -$17.14 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Income towards Parent Company since Q4 2023.
- According to Business Quant data, Income towards Parent Company for the three prior quarters was -$18.87 million (Q1 2026), -$16.86 million (Q4 2025) and $45.45 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | SAB Biotherapeutics | 248.81 Mn | 248.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22.49 Mn |
| Mar 31, 2026 | -18.87 Mn |
| Dec 31, 2025 | -16.86 Mn |
| Sep 30, 2025 | 45.45 Mn |
| Jun 30, 2025 | -10.11 Mn |
| Mar 31, 2025 | -5.20 Mn |
| Dec 31, 2024 | -11.39 Mn |
| Sep 30, 2024 | -10.35 Mn |
| Jun 30, 2024 | -7.34 Mn |
| Mar 31, 2024 | -5.03 Mn |
| Dec 31, 2023 | -22.86 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Jun 30, 2023 | -6.88 Mn |
| Mar 31, 2023 | -7.35 Mn |
| Dec 31, 2022 | -7.87 Mn |
| Sep 30, 2022 | -7.08 Mn |
| Jun 30, 2022 | -4.78 Mn |
| Mar 31, 2022 | 985,863.00 |
| Dec 31, 2021 | -11.55 Mn |
| Sep 30, 2021 | -4.06 Mn |
API Access
SAB Biotherapeutics Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();